Similar articles

• Induction of immune tolerance with factor VIII concentrate in patients with hemophilia A and inhibitors.

  Ewing NP. Ewing NP. Prog Clin Biol Res. 1990;324:59-68. Prog Clin Biol Res. 1990. PMID: 2106693 Review. No abstract available.
• Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.

  White GC 2nd, Greenwood R, Escobar M, Frelinger JA. White GC 2nd, et al. Haematologica. 2000 Oct;85(10 Suppl):113-6. Haematologica. 2000. PMID: 11187862 Review.
• Immunological and laboratory aspects of immune tolerance.

  Kazatchkine M, Hoyer L. Kazatchkine M, et al. Vox Sang. 1996;70 Suppl 1:52-9. Vox Sang. 1996. PMID: 8869470 No abstract available.
• [Porcine factor VIII].

  De Juan MJ, Montoro JB, Tusell JM. De Juan MJ, et al. Sangre (Barc). 1991 Jun;36(3):217-20. Sangre (Barc). 1991. PMID: 1948542 Review. Spanish. No abstract available.
• The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.

  Kessler CM, Ludlam CA. Kessler CM, et al. Semin Hematol. 1993 Apr;30(2 Suppl 1):22-7. Semin Hematol. 1993. PMID: 8480193 No abstract available.